Girisopam

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGirisopam
Drug Alias NameGYKI-51189EGIS-5810
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonistsGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptorGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIvax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnxiety

Other Information

ATC CodeN/A
Related LinksWikipedia